» Articles » PMID: 39911351

CKD Patients Comorbid with Hypertension Are Associated with Imbalanced Gut Microbiome

Overview
Journal iScience
Publisher Cell Press
Date 2025 Feb 6
PMID 39911351
Authors
Affiliations
Soon will be listed here.
Abstract

Intestinal flora has been linked to chronic kidney disease (CKD) and hypertension, respectively. This study aimed to investigate the microbial community among 54 individuals without CKD, 46 hypertensive CKD patients (CKD_HTN), and 48 non-hypertensive CKD patients. Variations in microbial diversity were detected in CKD. The -dominated type progressively increased from CKD to CKD_HTN. Based on the variation patterns, we identified six distinct clusters. , , and were enriched in CKD, whereas and were elevated, and and were reduced in CKD_HTN. Enhanced phenylalanine metabolism and siderophore group nonribosomal peptides biosynthesis from non-CKD to CKD were observed, particularly in CKD with hypertension. The connections between genera and KEGG pathways suggest an impact of microbial dysbiosis on metabolism. Our findings demonstrate that imbalances in gut microorganisms and functions are associated with increased susceptibility to hypertension in CKD patients and could be targeted for improving kidney function in CKD.

References
1.
Wang J, Gao Y, Ren S, Li J, Chen S, Feng J . Gut microbiota-derived trimethylamine N-Oxide: a novel target for the treatment of preeclampsia. Gut Microbes. 2024; 16(1):2311888. PMC: 10868535. DOI: 10.1080/19490976.2024.2311888. View

2.
Lyu F, Han F, Ge C, Mao W, Chen L, Hu H . OmicStudio: A composable bioinformatics cloud platform with real-time feedback that can generate high-quality graphs for publication. Imeta. 2024; 2(1):e85. PMC: 10989813. DOI: 10.1002/imt2.85. View

3.
Oikawa D, Yamashita S, Takahashi S, Waki T, Kikuchi K, Abe T . (+)-Sesamin, a sesame lignan, is a potent inhibitor of gut bacterial tryptophan indole-lyase that is a key enzyme in chronic kidney disease pathogenesis. Biochem Biophys Res Commun. 2022; 590:158-162. DOI: 10.1016/j.bbrc.2021.12.088. View

4.
Rahman A, Shin J, Whang C, Jung W, Yoo D, Seo C . Bilirubin Nanomedicine Rescues Intestinal Barrier Destruction and Restores Mucosal Immunity in Colitis. ACS Nano. 2023; 17(11):10996-11013. DOI: 10.1021/acsnano.3c03252. View

5.
Chen Y, Chen D, Chen L, Liu J, Vaziri N, Guo Y . Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease. J Transl Med. 2019; 17(1):5. PMC: 6317198. DOI: 10.1186/s12967-018-1756-4. View